Tutorials
Sumitomo Pharma Co Ltd logo

Sumitomo Pharma Co Ltd

$ 7.70 0 (0%) 09:40 AM EST
P/E:
5.38
P/B:
0.66
Market Cap:
$ 3.31B
Enterprise V:
$ 3.34B
Volume:
-
Avg Vol (2M):
600.00
Also Trade In:
Volume:
-
Market Cap $:
3.31B
PE Ratio:
5.38
Avg Vol (2-Month):
600.00
Enterprise Value $:
3.34B
PB Ratio:
0.66
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Sumitomo Pharma Co Ltd
NAICS : 325412
6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045
Description
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Name Current Vs Industry Vs History
Cash-To-Debt 0.99
Equity-to-Asset 0.47
Debt-to-Equity 0.4
Debt-to-EBITDA 1.62
Interest Coverage 23.19
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.83
Distress
Grey
Safe
Beneish M-Score -2.45
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 23.29
9-Day RSI 28.75
14-Day RSI 29.17
6-1 Month Momentum % -22.35
12-1 Month Momentum % -50.15

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.74
Quick Ratio 1.39
Cash Ratio 0.83
Days Inventory 217.82
Days Sales Outstanding 100.07
Days Payable 119.53

Dividend & Buy Back

Name Current Vs Industry Vs History
Dividend Yield % 2.95
Dividend Payout Ratio 0.13
Forward Dividend Yield % 2.8
5-Year Yield-on-Cost % 4.88

Financials

DNPUF's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with OTCPK:DNPUF

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 4,963.326
EPS (TTM) ($) 1.739
Beta 0.86
Volatility % 36.36
14-Day RSI 29.17
14-Day ATR ($) 0.021091
20-Day SMA ($) 7.7
12-1 Month Momentum % -50.15
52-Week Range ($) 7.6 - 17.4
Shares Outstanding (Mil) 397.29

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sumitomo Pharma Co Ltd Filings

Document Form Filing Date
No Filing Data

Headlines

See More